Skip to main content
ATRC
NASDAQ Industrial Applications And Services

AtriCure Reports Strong Q1 2026 Results with 14.3% Revenue Growth and Shift to Profitability

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$29.39
Mkt Cap
$1.484B
52W Low
$26.62
52W High
$43.18
52W Position info
10% above low
Off High info
32% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

ATRC is trading near its 52-week low of $26.62 (10% above the low).

Summary

AtriCure, Inc. announced strong first-quarter 2026 financial results, featuring 14.3% worldwide revenue growth, a shift to net income, and a 95% increase in adjusted EBITDA, alongside positive full-year guidance.


Key Events · Earnings and Guidance · ATRC

  • Strong Revenue Growth

    Worldwide revenue for Q1 2026 reached $141.2 million, marking a 14.3% increase year-over-year. U.S. revenue growth accelerated to 14.9%, driven by key product lines.

  • Shift to Profitability

    The company reported net income of $0.1 million for Q1 2026, a significant improvement from a net loss of $6.7 million in Q1 2025. Basic and diluted net income per share was breakeven at $0.00.

  • Substantial EBITDA Growth

    Adjusted EBITDA for Q1 2026 increased by 95% year-over-year to $17.1 million, reflecting enhanced operational efficiency.

  • Improved Gross Margin

    Gross margin for the first quarter improved by 246 basis points to 77.4%, primarily due to favorable product and geographic mix.


Analysis · ATRC · Industrial Applications And Services

AtriCure, Inc. delivered robust first-quarter results, demonstrating accelerated revenue growth and a significant turnaround in profitability. The company's ability to achieve net income after reporting a loss in the prior year, coupled with substantial adjusted EBITDA growth and improved gross margins, indicates strong operational execution. The positive full-year 2026 guidance further reinforces a confident outlook, suggesting continued momentum in its core markets and product lines. This performance provides a solid foundation for the company's growth trajectory.

At the time of this filing, ATRC was trading at $29.39 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $26.62 to $43.18. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATRC - Latest Insights

ATRC
Jul 27, 2026, 1:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $37.31
Real-time Price: $39.49 info
Change: +$2.18 (+6%) info
Market Cap: $2.009B info
ATRC
Jul 23, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.71
Real-time Price: $39.49 info
Change: +$4.78 (+14%) info
Market Cap: $2.009B info
ATRC
May 19, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.80
Real-time Price: $39.49 info
Change: +$10.69 (+37%) info
Market Cap: $2.009B info
ATRC
May 05, 2026, 9:01 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $30.40
Real-time Price: $39.49 info
Change: +$9.09 (+30%) info
Market Cap: $2.009B info
ATRC
May 05, 2026, 4:23 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $29.50
Real-time Price: $39.49 info
Change: +$9.99 (+34%) info
Market Cap: $2.009B info